The DAFNEplus programme for sustained type 1 diabetes self management: Intervention development using the Behaviour Change Wheel.
Stephanie H Stanton-Fay, Kathryn Hamilton, Paul M Chadwick...
https://pubmed.ncbi.nlm.nih.gov/33617669/Actively Recruiting
Led by McGill University · Updated on 2025-09-25
322
Participants Needed
4
Research Sites
21 weeks
Total Duration
Researchers are evaluating an online training and support platform called Support to help adults living with type 1 diabetes T1D manage their condition. The study aims to compare the effects of integrating this platform into regular medical care versus accessing it independently. The trial also explores factors influencing the platforms use in real-life settings and involves adults from across Canada, including those followed at four specific clinics in Quebec. Participants will be divided into two groups. One group will access the Support platform as part of their usual care, with healthcare professionals incorporating it during appointments. The other group will use the platform independently without direct integration into their medical visits. Both groups will have access to the platform for 12 months, receiving monthly newsletters and features like educational content, news blogs, and peer discussion forums, all designed to support diabetes self-management. Throughout the study, participants will complete online questionnaires at the start, 6 months, and 12 months to assess their self-efficacy and well-being. They will also share continuous glucose monitoring data and other health outcomes such as severe hypoglycemic events and diabetic ketoacidosis occurrences. A subgroup and healthcare professionals will take part in interviews to discuss experiences using the platform. The study runs from May 2024 to October 2027.
CONDITIONS
Implementation of Support in the Care of Adults Living With Type 1 Diabetes
A
Anne-Sophie Brazeau, PhD
A
amelie Roy-Fleming, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
McGill University
Lead Sponsor
Institut de Recherches Cliniques de Montreal
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Duration - 12 months
Participants receive access to the Support platform for diabetes self-management education, either integrated into their usual care or independently, along with monthly newsletters to encourage platform use.
2 to 3 visits with medical team during this period, either in-person, remote, or hybrid
Duration - 12 months
Participants complete online surveys at baseline, 6 months, and 12 months to assess self-efficacy and other health outcomes related to diabetes management.
3 online survey completions
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Stephanie H Stanton-Fay, Kathryn Hamilton, Paul M Chadwick...
https://pubmed.ncbi.nlm.nih.gov/33617669/Li Feng Xie, Alexandra Itzkovitz, Amelie Roy-Fleming...
https://pubmed.ncbi.nlm.nih.gov/32788152/J Kruger, A Brennan, P Thokala...
https://pubmed.ncbi.nlm.nih.gov/23815547/Li Feng Xie, Amélie Roy-Fleming, Sarah Haag...
https://pubmed.ncbi.nlm.nih.gov/36762025/Andreas Schmitt, Bernhard Kulzer, Dominic Ehrmann...
https://pubmed.ncbi.nlm.nih.gov/36994332/Katherine Pereira, Beth Phillips, Constance Johnson...
https://pubmed.ncbi.nlm.nih.gov/25238257/Geoffrey M Curran, Mark Bauer, Brian Mittman...
https://pubmed.ncbi.nlm.nih.gov/22310560/McGill University
Lead Sponsor
Institut de Recherches Cliniques de Montreal
Collaborating Sponsor